NIA Interventions Testing Program: A Collaborative Approach for Investigating Interventions to Promote Healthy Aging

Handbook of the Biology of Aging: Eighth Edition

Volumn , Issue , 2016, Pages 287-303

  Nadon, Nancy L ^a   Miller, Richard A ^b   Strong, Randy ^c,d   Harrison, David E ^e  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c University of Texas Health Science Center   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e JACKSON LABORATORY   (United States)

Author keywords

Healthspan; Heterogeneous mice; Lifespan; Longevity

Indexed keywords

EID: 84966781457     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-411596-5.00010-1     Document Type: Chapter

References (34)

1. Bendele A.M., Carlton W.W. Incidence of obstructive uropathy in male B6C3F1 mice on a 24-month carcinogenicity study and its apparent prevention by ochratoxin A. Lab. Anim. Sci. 1986, 36:282-285.
2. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science 1999, 284:1670-1672.
3. Engelhardt J.A., Gries C.L., Long G.G. Incidence of spontaneous neoplastic and nonneoplastic lesions in Charles River CD-1 mice varies with breeding origin. Toxicol. Pathol. 1993, 21:538-541.
4. Evason K., Huang C., Yamben I., Covey D.F., Kornfeld K. Anticonvulsant medications extend worm life span. Science 2005, 307:258-262.
5. Everitt J.I., Ross P.W., Davis T.W. Urologic syndrome associated with wire caging in AKR mice. Lab. Anim. Sci. 1988, 38:609-611.
6. Gems D. Long-lived dwarf mice: are bile acids a longevity signal?. Aging Cell 2007, 6:421-423.
7. Hajek R.A., Robertson A.D., Johnston D.A., Van N.T., Tcholakian R.K., Wagner L.A., et al. During development, 17alpha-estradiol is a potent estrogen and carcinogen. Environ. Health Perspect. 1997, 105(Suppl. 3):577-581.
8. Harper J.M., Galecki A.T., Burke D.T., Pinkosky S.L., Miller R.A. Quantitative trait loci for insulin-like growth factor-I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice. Physiol. Genomics 2003, 15:44-51.
9. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
10. Harrison D.E., Strong R., Allison D.B., Ames B.N., Astle C.M., Atamna H., et al. Acarbose, 17α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell 2014, 13:273-282.
11. Johnson S.C., Martin G.M., Rabinovitch P.S., Kaeberlein M. Preserving youth: does rapamycin deliver?. Sci. Transl. Med. 2013, 5(211):211fs40.
12. Lamming D.W., Ye L., Astle C.M., Baur J.A., Sabatini D.M., Harrison D.E. Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive. Aging Cell 2013, 12(4):712-718.
13. Miller R.A., Chrisp C. Lifelong treatment with oral DHEA sulfate does not preserve immune function, prevent disease, or improve survival in genetically heterogeneous mice. J. Am. Geriatr. Soc 1999, 47:960-966.
14. Miller R.A., Austad S., Burke D., Chrisp C., Dysko R., Galecki A., et al. Exotic mice as models for aging research: polemic and prospectus. Neurobiol. Aging 1999, 20:217-231.
15. Miller R.A., Burke D., Nadon N. Announcement: four-way cross mouse stocks: a new, genetically heterogeneous resource for aging research. J Gerontol. Biol. Sci. 1999, 54:B358-B360.
16. Miller R.A., Harrison D.E., Astle C.M., Floyd R.A., Flurkey K., Hensley K.L., et al. NIA interventions testing program: study design and an interim report. Aging Cell 2007, 6:565-575.
17. Miller R.A., Harrison D., Astle C.M., Baur J.A., deCabo R., Fernandez E., et al. Rapamycin, but not resveratrol or simvastatin, extends lifespan of genetically heterogeneous mice. J. Gerontol. Biol. Sci. 2011, 66A:191-201.
18. Miller R.A., Harrison D.E., Astle C.M., Fernandez E., Flurkey K., Han M., et al. Rapamycin-mediated lifespan increase in mice is dose and sex-dependent and metabolically distinct from dietary restriction. Aging Cell 2014, 13:468-477.
19. Nadon N.L., Strong R., Miller R.A., Nelson J., Javors M., Sharp Z.D., et al. Design of aging intervention studies: the NIA interventions testing program. Age 2008, 30:187-199.
20. Neff F., Flores-Dominguez D., Ryan D.P., Horsch M., Schröder S., Adler T., et al. Rapamycin extends murine lifespan but has limited effects on aging. J. Clin. Invest. 2013, 123:3272-3291.
21. Richardson A. Rapamycin, anti-aging, and avoiding the fate of Tithonus. J. Clin. Invest. 2013, 123:3204-3206.
22. Roderick T.H. Selection for radiation resistance in mice. Genetics 1963, 48:205-216.
23. Sharp Z.D., Strong R. The role of mTOR signaling in controlling mammalian life span: what a fungicide teaches us about longevity. J. Gerontol. Biol. Sci. 2010, 65:580-589.
24. Steinbaugh M.J., Sun L.Y., Bartke A., Miller R.A. Activation of genes involved in xenobiotic metabolism is a shared signature of mouse models with extended lifespan. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E488-E495.
25. Strong R., Miller R.A., Astle C.M., Floyd R.A., Flurkey K., Hensley K.L., et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 2008, 7:641-650.
26. Strong R., Miller R.A., Astle C.M., Baur J.A., de Cabo R., Fernandez E., et al. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium chain triglyceride oil on lifespan of genetically heterogeneous mice. J. Gerontol. Biol. Sci. 2013, 68:6-16.
27. Tanaka E., Ishikawa A., Horie T. In vivo and in vitro trimethadione oxidation activity of the liver from various animal species including mouse, hamster, rat, -rabbit, dog, monkey and human. Hum. Exp. Toxicol. 1999, 18:12-16.
28. Tuffery A.A. Urogenital lesions in laboratory mice. J. Pathol. Bacteriol. 1966, 91:301-309.
29. Van Gelder R.N., Hogenesh J.B. Clean thoughts about dirty genes. J. Biol. Rythms 2004, 19:3-9.
30. Wang C., Li Q., Redden D.T., Weindruch R., Allison D.B. Statistical methods for testing effects on "maximum lifespan". Mech. Ageing Dev. 2004, 125:629-632.
31. Warner H.R., Ingram D., Miller R.A., Nadon N.L., Richardson A.G. Meeting report: program for testing biological interventions to promote healthy aging. Mech. Ageing Dev. 2000, 115:199-208.
32. Wilkinson J.E., Burmeister L., Brooks S.V., Chan C.-C., Friedline S., Harrison D., et al. Rapamycin slows aging in mice. Aging Cell 2012, 11:675-682.
33. Ye L., Widlund A.L., Sims C.A., Lamming D.W., Guan Y., Davis J.G., et al. Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance. Aging 2013, 5:539-550.
34. Zhang Y., Bokov A., Gelfond J., Soto V., Ikeno Y., Hubbard G., et al. Rapamycin extends life and health in C57BL/6 mice. J. Gerontol. Biol. Sci. 2014, 69:119-130.